Neonatal cerebral leukomalacia
ICD-10 P91.2 is a billable code used to indicate a diagnosis of neonatal cerebral leukomalacia.
Neonatal cerebral leukomalacia (NCL) is a condition characterized by the softening of white matter in the brain of a newborn, often due to ischemic injury. This condition is primarily seen in premature infants and can lead to significant neurodevelopmental impairments. The pathophysiology involves the disruption of blood flow to the periventricular white matter, resulting in necrosis and subsequent gliosis. Clinically, infants may present with signs of neurological disturbances, including hypotonia, seizures, and altered consciousness. The diagnosis is typically confirmed through imaging studies such as MRI, which can reveal areas of white matter damage. Early identification and intervention are crucial for improving outcomes, as affected infants may require multidisciplinary care, including physical therapy, occupational therapy, and ongoing developmental assessments. The long-term prognosis varies, with some infants experiencing significant developmental delays while others may have milder outcomes.
Detailed neurological assessments, imaging results, and developmental follow-up notes.
Infants in the NICU presenting with hypotonia and seizures, requiring neurological evaluation.
Ensure accurate coding of associated conditions and interventions.
Comprehensive developmental assessments and history of perinatal complications.
Pediatric follow-up visits for infants diagnosed with NCL, monitoring developmental milestones.
Consider the long-term implications of NCL on pediatric care and development.
Used when managing an infant with NCL in the NICU.
Detailed notes on the infant's condition, interventions, and response to treatment.
Neonatologists should ensure comprehensive documentation to support critical care coding.
Long-term outcomes can vary widely; some infants may experience significant developmental delays, while others may have milder impairments. Early intervention services are crucial for improving developmental outcomes.
